<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art><ui>ar3949</ui><ji>1478-6354</ji><fm>
<dochead>Meeting abstract</dochead>
<bibl>
<title>
<p>Lung cancer in systemic lupus erythematosus</p>
</title>
<aug>
<au id="A1"><snm>Kale</snm><fnm>M</fnm><insr iid="I1"/></au>
<au id="A2"><snm>Ramsey-Goldman</snm><fnm>R</fnm><insr iid="I2"/></au>
<au id="A3"><snm>Bernatsky</snm><fnm>S</fnm><insr iid="I1"/></au>
<au id="A4"><snm>Urowitz</snm><fnm>MB</fnm><insr iid="I3"/></au>
<au id="A5"><snm>Gladman</snm><fnm>D</fnm><insr iid="I3"/></au>
<au id="A6"><snm>Fortin</snm><fnm>PR</fnm><insr iid="I4"/></au>
<au id="A7"><snm>Petri</snm><fnm>M</fnm><insr iid="I5"/></au>
<au id="A8"><snm>Yelin</snm><fnm>E</fnm><insr iid="I6"/></au>
<au id="A9"><snm>Manzi</snm><fnm>S</fnm><insr iid="I7"/></au>
<au id="A10"><snm>Edworthy</snm><fnm>S</fnm><insr iid="I8"/></au>
<au id="A11"><snm>Nived</snm><fnm>O</fnm><insr iid="I9"/></au>
<au id="A12"><snm>Bae</snm><fnm>S-C</fnm><insr iid="I10"/></au>
<au id="A13"><snm>Isenberg</snm><fnm>D</fnm><insr iid="I11"/></au>
<au id="A14"><snm>Rahman</snm><fnm>A</fnm><insr iid="I11"/></au>
<au id="A15"><snm>Hanly</snm><fnm>JG</fnm><insr iid="I12"/></au>
<au id="A16"><snm>Gordon</snm><fnm>C</fnm><insr iid="I13"/></au>
<au id="A17"><snm>Jacobsen</snm><fnm>S</fnm><insr iid="I14"/></au>
<au id="A18"><snm>Ginzler</snm><fnm>E</fnm><insr iid="I15"/></au>
<au id="A19"><snm>Wallace</snm><fnm>DJ</fnm><insr iid="I16"/></au>
<au id="A20"><snm>Alarc&#243;n</snm><fnm>GS</fnm><insr iid="I17"/></au>
<au id="A21"><snm>Dooley</snm><fnm>MA</fnm><insr iid="I18"/></au>
<au id="A22"><snm>Gottesman</snm><fnm>L</fnm><insr iid="I15"/></au>
<au id="A23"><snm>Steinsson</snm><fnm>K</fnm><insr iid="I19"/></au>
<au id="A24"><snm>Zoma</snm><fnm>A</fnm><insr iid="I20"/></au>
<au id="A25"><snm>Sen&#233;cal</snm><fnm>J-L</fnm><insr iid="I21"/></au>
<au id="A26"><snm>Barr</snm><fnm>S</fnm><insr iid="I8"/></au>
<au id="A27"><snm>Sturfelt</snm><fnm>G</fnm><insr iid="I9"/></au>
<au id="A28"><snm>Dreyer</snm><fnm>L</fnm><insr iid="I22"/></au>
<au id="A29"><snm>Criswell</snm><fnm>L</fnm><insr iid="I6"/></au>
<au id="A30"><snm>Sibley</snm><fnm>J</fnm><insr iid="I23"/></au>
<au id="A31"><snm>Lee</snm><fnm>JL</fnm><insr iid="I1"/></au>
<au ca="yes" id="A32"><snm>Clarke</snm><fnm>AE</fnm><insr iid="I1"/></au>
</aug>
<insg>
<ins id="I1"><p>McGill University Health Centre, Montreal, QC, Canada</p></ins>
<ins id="I2"><p>Northwestern University Feinberg School of Medicine, Chicago, IL, USA</p></ins>
<ins id="I3"><p>Toronto Western Hospital, Toronto, ON, Canada</p></ins>
<ins id="I4"><p>Universit&#233; de Laval, QC, Canada</p></ins>
<ins id="I5"><p>Johns Hopkins University School of Medicine, Baltimore, MD, USA</p></ins>
<ins id="I6"><p>University of California, San Francisco, CA, USA</p></ins>
<ins id="I7"><p>West Penn Allegheny Health System, Pittsburgh, PA, USA</p></ins>
<ins id="I8"><p>University of Calgary, AB, Canada</p></ins>
<ins id="I9"><p>Lund University Hospital, Lund, Sweden</p></ins>
<ins id="I10"><p>The Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea</p></ins>
<ins id="I11"><p>University College, London, UK</p></ins>
<ins id="I12"><p>Dalhousie University and Capital Health, Halifax, NS, Canada</p></ins>
<ins id="I13"><p>College of Medical and Dental Sciences, University of Birmingham, UK</p></ins>
<ins id="I14"><p>Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark</p></ins>
<ins id="I15"><p>State University of New York - Downstate Medical Center, Brooklyn, NY, USA</p></ins>
<ins id="I16"><p>Cedars-Sinai Medical Center/David Geffen School of Medicine, University of California Los Angeles, CA, USA</p></ins>
<ins id="I17"><p>The University of Alabama, Birmingham, AL, USA</p></ins>
<ins id="I18"><p>University of North Carolina at Chapel Hill, NC, USA</p></ins>
<ins id="I19"><p>Landspitali University Hospital, Reykjavik, Iceland</p></ins>
<ins id="I20"><p>Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, UK</p></ins>
<ins id="I21"><p>Universit&#233; de Montr&#233;al, QC, Canada</p></ins>
<ins id="I22"><p>Copenhagen University Hospital, Copenhagen, Denmark</p></ins>
<ins id="I23"><p>Royal University Hospital, Saskatoon, Saskatchewan, Canada</p></ins>
</insg>
<source>Arthritis Research &amp; Therapy</source>


<supplement><title><p>Lupus 2012: New targets, new approaches</p></title><editor>Peter E Lipsky, John M Esdaile, Matthew H Liang and Paul R Fortin</editor><note>Meeting abstracts</note></supplement><conference><title><p>Lupus 2012: New targets, new approaches</p></title><location>Whistler, Canada</location><date-range>27-30 September 2012</date-range></conference><issn>1478-6354</issn>
<pubdate>2012</pubdate>
<volume>14</volume>
<issue>Suppl 3</issue>
<fpage>A15</fpage>
<url>http://arthritis-research.com/content/14/S3/A15</url>
<xrefbib><pubid idtype="doi">10.1186/ar3949</pubid></xrefbib>
</bibl>
<history><pub><date><day>27</day><month>9</month><year>2012</year></date></pub></history>
<cpyrt><year>2012</year><collab>Kale et al.; licensee BioMed Central Ltd.</collab><note>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</note></cpyrt>
</fm><bdy>
<sec>
<st>
<p>Background</p>
</st>
<p>An increased lung cancer risk in SLE has been suggested in the literature <abbrgrp>
<abbr bid="B1">1</abbr>
</abbrgrp>. Our objective was to provide an updated analyses of the lung cancer cases from a multi-site international cohort study, including descriptive statistics of the demographics (age, sex, and race/ethnicity) of cases, as well the of histology.</p>
</sec>
<sec>
<st>
<p>Methods</p>
</st>
<p>Data from an SLE sample of 15,980 SLE patients from 28 centers were analyzed (in Canada, the United States, the United Kingdom, Denmark, Sweden, Scotland, Korea and Iceland). Information on date of birth, sex and race was available, along with the date of SLE diagnosis. Cancer occurrence was ascertained through linkages with regional tumor registries. We assessed the demographic characteristics for all lung cancer cases in the SLE patients, and information on histology types was analyzed from the centers where this information was available.</p>
</sec>
<sec>
<st>
<p>Results</p>
</st>
<p>In the current analyses, 101 lung cancer cases that had occurred after SLE diagnosis were studied. The lung cancer cases were distributed across 21 centers. The average age of the SLE patients at lung cancer diagnosis was 60 years (median 40, standard deviation (SD) 10.9). The average SLE duration at the time of lung cancer diagnosis was 13 years (median 12, SD 10.6). Race/ethnicity was not provided by six centers (35 cases). Of the remaining 66 cases, the majority were Caucasian (<it>n </it>= 54, 53.5%) followed by nine African-American, one Asian, one Pacific-Islander and one of unknown racial/ethnic origin. Histological lung cancer type was only provided by 12 centers (59 cases). The most common histological type reported within these 59 cases was squamous cell carcinoma (<it>n </it>= 15, 25.4%; 95% CI = 16.1 to 37.8) followed by adenocarcinoma (<it>n </it>= 13, 22%; 95% CI = 13.4 to 34.1) and nonsmall-cell carcinoma (<it>n </it>= 5, 8.5%; 95% CI = 3.7 to 18.4). The remaining 44% were composed of carcinomas not otherwise specified and a variety of uncommon tumors: large cell, clear cell, solid, bronchoalveolar, adenosquamous, epithelial hemangioendothelioma, oat cell, carcinoid, small cell and mucinous histological types.</p>
</sec>
<sec>
<st>
<p>Conclusion</p>
</st>
<p>In the general population, about 30 to 40% of lung cancer cases are adenocarcinoma, with 20 to 30% squamous cell carcinoma, and 10% large cell carcinoma <abbrgrp>
<abbr bid="B2">2</abbr>
</abbrgrp>. Our results suggest a similar distribution, but with a possibly lower proportion of adenocarcinomas, and a higher number of uncommon lung cancer types. Further work is planned to assess other features of these cancers.</p>
</sec>
</bdy><bm>
<refgrp><bibl id="B1"><title><p>Further defining cancer risk in systemic lupus: updated results in an expanded international multi-centre cohort [abstract]</p></title><aug><au><snm>Bernatsky</snm><fnm>S</fnm></au><au><snm>Clarke</snm><fnm>A</fnm></au><au><snm>Petri</snm><fnm>MA</fnm></au><etal/></aug><source>Arthritis Rheum</source><pubdate>2010</pubdate><volume>62</volume><fpage>S731</fpage></bibl><bibl id="B2"><title><p>Lung cancer in systemic lupus erythematosus</p></title><aug><au><snm>Bin</snm><fnm>J</fnm></au><au><snm>Bernatsky</snm><fnm>S</fnm></au><au><snm>Gordon</snm><fnm>C</fnm></au><etal/></aug><source>Lung Cancer</source><pubdate>2007</pubdate><volume>56</volume><fpage>303</fpage><lpage>306</lpage><xrefbib><pubidlist><pubid idtype="doi">10.1016/j.lungcan.2007.01.007</pubid><pubid idtype="pmpid" link="fulltext">17291624</pubid></pubidlist></xrefbib></bibl></refgrp>
</bm></art>